Lice Treatment Market Research Report – Forecast till 2027

Lice Treatment Market Research Report, by type (pediculosis capitis, pediculosis corporis, pediculosis pubis), treatment (OTC products, prescription medications), distribution channel (online platform, hospitals & clinics) - Forecast till 2027

Q: Which region has the maximum Lice Treatment Market share?

Americas have a maximum Lice Treatment Market share.. Read More

ID: MRFR/Pharma/5668-HCR | February 2021 | Region: Global | 90 pages

Lice Treatment Market Scenario

The Lice Treatment Market is expected to register a CAGR of 6.5% during the forecast period of 2018 to 2023. Lice are parasites that feed on human blood, mostly from the head and pubic areas. The medical condition can be infested to others by close contact with carrier or through pets. In recent years, the prevalence of head lice has increased, resulting in a parallel demand for therapeutics. According to an article published by the Centers for Disease Control and Prevention in 2015, it was estimated that ~6 million to 12 million infestations occur each year within the U.S. Moreover, the article further stated that most of the reported cases were for children who aged 3 to 11 years. Trends in the population composition, suggests that this susceptible population has increased. As per the international database of U.S. Census Bureau, there were ~3,416,831 children who aged 5-9 years within Germany. Thus, such high patient pool is projected to fuel the market.

Conclusively, it is observed that high prevalence of head lice and growing children population majorly drives the market. Moreover, factors such as increasing disposable income and rising healthcare expenditure provides suitable boost for the market growth. Contrary to the illustrated facts, it is mentionable that lack of awareness and low per capita healthcare expenditure in the developing and low-income countries restricts the market growth.

Segmentation

The lice treatment market is segmented based on type, treatment, end user, and region.

On the basis of type, the market is segmented into pediculosis capitis, pediculosis corporis, and pediculosis pubis. Based on treatment, the market is devised into two, i.e., OTC (over the counter) products and prescription medications. The OTC medication segment is sub-segmented into permethrin, pyrethrin, and others. The prescription segment is sub-segmented into ivermectin, spinosad, malathion, and others. By end user, the market is divided into hospitals & clinics, retail pharmacies, online platform. In the current scope of the study, the above-mentioned segments are covered into four global regions, namely- the Americas, Europe, Asia Pacific and the Middle East & Africa.

Regional Market Summary

Lice treatment Market Share (%), by Region, 2017

Sources: Centers for Disease Control and Prevention, U.S. Census Bureau, Kodiak Island Borough School District Annual Reports, Press Release, White Paper, And Company Presentation

The Americas dominated the global market for lice treatment owing to rising children population and presence of major market players within the region. According to the database of the U.S. Census Bureau, it was estimated that there were approximately 20,304,238 children who aged 5-9 years within the region. Moreover, the presence of developed economies and healthcare sector within the region boosts the market growth.

In 2017, it was estimated that Europe stood second in the lice treatment market. This can be attributed due to the presence of a well-developed healthcare infrastructure, increasing awareness for the condition and presence of developed economies within the region.

Asia Pacific was the fastest growing region for the lice treatment market in 2017. Factors such high contamination rate, increasing household income and growing penetration of the market players within the region drives the market within the region. A study published in 2014 by the International Journal of Community Based Nursing and Midwifery journal stated that estimated rate of lice contamination was 16.59% in India.

On the other hand, the Middle East and Africa held least share in the lice treatment market. Presence of poor economies and low per capita income, especially within the African region make the market to lag within the region. Most of the market share within this region is estimated to be held by the Middle East due to increasing government funding in the healthcare, and presence of developed economies like UAE, Kuwait, Dubai, and others.

Key players

Some of the key players in the lice treatment market are AkzoNobel N.V., Alliance Pharmaceuticals Ltd., Bayer HealthCare, Dow AgroSciences LLC, Elanco, GlaxoSmithKline, Insight Pharmaceuticals, Johnson & Johnson, Omega Pharma, Pfizer, Sanofi, Suven Life Sciences, Taro Pharmaceuticals, Topaz Pharmaceuticals Inc., and others

Research Methodology

Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analysing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.

Primary Research

Extensive primary research was conducted to gain a deeper insight of the market and the industry performance. In this particular report we have conducted primary surveys (interviews) with key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.

Secondary Research

Secondary research was mainly used to collect and identify information useful for extensive, technical, market-oriented, and commercial study of the lice treatment market. It was also used to obtain key information about major players, market classification, and segmentation according to industry trends, geographical markets, and developments related to the market and perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company web sites, international organization of chemical manufacturers, some paid databases, and many others.

Intended Audience:

Pharmaceutical companies

Government and private laboratories

Research and Development (R&D) companies

Medical research laboratories

Market research and consulting service providers

Market Segmentation and Key Market Players:

Lice treatment Market, by Type:

Pediculosis Capitis

Pediculosis Corporis

Pediculosis Pubis

Lice Treatment Market, by Treatment:

OTC Products

Permethrin

Pyrethrin

Others

Prescription Medications

Ivermectin

Spinosad

Malathion

Others

Lice treatment Market, by End-User:

Hospitals & Clinics

Retail Pharmacies

Online Platform

Lice Treatment Market, by Key Players:

AkzoNobel N.V.

Alliance Pharmaceuticals Ltd.

Bayer HealthCare

Dow AgroSciences LLC

Elanco

GlaxoSmithKline

Insight Pharmaceuticals

Johnson & Johnson

Omega Pharma

Pfizer

Sanofi

Suven Life Sciences

Taro Pharmaceuticals

Topaz Pharmaceuticals Inc.

Report Scope:

Report Attribute/Metric	Details
Market Size	2027: Significant Value
CAGR	6.5% (2018-2023)
Base Year	2019
Forecast Period	2020-2027
Historical Data	2018
Forecast Units	Value (USD Million)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Type, Treatment, End user
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	AkzoNobel N.V., Alliance Pharmaceuticals Ltd., Bayer HealthCare, Dow AgroSciences LLC, Elanco, GlaxoSmithKline, Insight Pharmaceuticals, Johnson & Johnson, Omega Pharma, Pfizer, Sanofi, Suven Life Sciences, Taro Pharmaceuticals, Topaz Pharmaceuticals Inc., and others
Key Market Opportunities	Increasing disposable income Rising healthcare expenditure
Key Market Drivers	High prevalence of head lice Growing children population

Frequently Asked Questions (FAQ) :

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Lice Treatment Market, by Type

6.1 Introduction

6.2 Pediculosis Capitis

Market Estimates & Forecast, by Region, 2020–2027